Description
Why choose this
The 7.5mg strength is a step up from 5mg, used after at least four weeks at the lower dose when your clinician agrees you need more support with appetite or weight progress. Your strength is confirmed after your Velthera assessment and professional review.
Product overview
Mounjaro is Eli Lilly's branded tirzepatide. Each listing is a one-month supply of four once-weekly doses.
Tirzepatide acts on the GIP and GLP-1 receptors that help regulate appetite and blood sugar, so you feel satisfied with less food and cravings become easier to manage. Choose Mounjaro if you would rather use the originator brand.
How to use
Inject once a week on the same day, under the skin of your stomach, thigh or upper arm. Your starting strength and any increases are set after your Velthera assessment and professional review.
Safety
The most common side effects are nausea, diarrhoea, constipation and reduced appetite, mostly when you start or move up a strength. Mounjaro is not suitable during pregnancy or breastfeeding, or for anyone with a personal or family history of medullary thyroid cancer or MEN2. Tell us about any history of pancreatitis or gallbladder problems during your assessment.
Reviews
There are no reviews yet.